AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
GILD vs VRTX Fundamental Comparison
| Metric | GILD | VRTX |
|---|---|---|
| Revenue | $7.0B | $3.0B |
| Net Income | $2.0B | $1.0B |
| Net Margin | 29.0% | 34.5% |
| ROE | 8.6% | 5.3% |
| ROA | 3.6% | 3.9% |
| Current Ratio | 1.97x | 3.02x |
| Debt/Equity | 0.94x | 0.01x |
| EPS | $1.61 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GILD vs VRTX: Frequently Asked Questions
Is GILD or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. GILD is graded A (78% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does GILD compare to VRTX fundamentally?
GILEAD SCIENCES, INC. has ROE of 8.6% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are 29.0% vs 34.5% respectively.
Which stock pays higher dividends, GILD or VRTX?
GILD has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GILD or VRTX for long term?
For long-term investing, consider that GILD has a A grade with 78% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GILD vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GILD vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.